RE:FOSSI**Fossi,
LIke yourself, I got in early, for me it was in 2014. CZO delivered EPS of .08 for 2015 up from .03 in 2014. The company was in a planned expansion to have production capacity up "10x".
At $2.50/share and trading at 30X trailing earnings and potential for explosive earnings growth in 2016 perhaps 200% to 300% does not make the stock overvalued.
As you said the market was looking forward. No obscene valuation there. They just did not deliver the rev growth that BNN analysts had expected as well.
Encouraging to see patient buyers today with orders at .70. A good NR of any kind should make them hit the ask and move this back over .90 in short time.
fossi_2002 wrote: ISA - the worst thing you can do on the stock market is to look back.
Ceapro has several irons in the fire - and one thing is clear - not all of them can ignite.
In 2015 I bought a large lot between 25c and 30c and sold it too early at around 1.50
2.50 were crazy in my eyes.
175 million stock market valuation with 10 million sales were not realistic.
Today we have a stock market valuation of a little over 50 million with a turnover of 16 million. ISA - if you don´t believe in the future of Ceapro, I recommend a sale - Stinzo has shown it.